{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 1128"}, "official-title": {"#tail": "\n\t", "#text": "To clarify the orphan drug exception to the annual fee on\n\t\t  branded prescription pharmaceutical manufacturers and\n\t\t  importers."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "#text": "June 11, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSFI00", "#text": "Committee\n\t\t\t on Finance"}, "sponsor": {"#tail": " (for himself,\n\t\t\t ", "#text": "Mr. Toomey", "@name-id": "S351"}, "cosponsor": [{"#tail": ", and ", "#text": "Mr. Casey", "@name-id": "S309"}, {"#tail": ") introduced the following bill; which was\n\t\t\t read twice and referred to the ", "#text": "Mr. Crapo", "@name-id": "S266"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "\n            Preserving Access to Orphan Drugs Act\n\t\t\t of 2013\n          "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "id64E34FE6BA7241F7BD9DAFA155AD7940"}, {"@section-type": "subsequent-section", "#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Clarification of\n\t\t\t orphan drug exception to annual fee on branded prescription pharmaceutical\n\t\t\t manufacturers and importers"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Paragraph (3) of\n\t\t\t section 9008(e)\n             of the \n              Patient Protection and Affordable Care Act", "@value": "Patient Protection and Affordable Care Act/s:9008/ss:e/p:3"}, {"#tail": ".; ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " note prec", "@entity-type": "uscode", "#text": "26 U.S.C.\n\t\t\t 4001", "@value": "usc/26/4001"}, "@entity-type": "uscode", "#text": "\n              ", "@value": "usc/26/4001/note"}], "@entity-type": "law-citation", "#text": "\n            \n              ", "external-xref": {"#tail": ")\n          ", "@parsable-cite": "pl/111/148", "#text": "Public Law 111\u2013148", "@legal-doc": "public-law"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "subparagraph": [{"#tail": "\n            ", "clause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of the\n\t\t\t\t", "@entity-type": "act", "#text": "section 45C", "@value": "Internal Revenue Code of 1986/s:45C"}, {"#tail": "\n                  ", "@entity-type": "act", "#text": "Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986"}], "@entity-type": "act", "#text": "\n                    ", "@value": "Internal Revenue Code of 1986/s:45C"}, "#text": "with respect to\n\t\t\t\twhich a credit was allowed for any taxable year under "}, "enum": {"#tail": "\n                ", "#text": "(i)"}, "#text": "\n                ", "@id": "H0E8214AB0ECC42EE87168BCE9F9AFD54", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for marketing solely for one or\n\t\t\t\tmore rare diseases or conditions.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "which is approved\n\t\t\t\tor licensed by the "}, "enum": {"#tail": "\n                ", "#text": "(ii)"}, "#text": "\n                ", "@id": "HF708024C1FF14B80B7DCC17B8D17AE9B", "@commented": "no"}], "enum": {"#tail": "\n              ", "#text": "(A)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " shall not include sales of any\n\t\t\t\tdrug or biological product\u2014", "#text": "branded prescription drug sales"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "@id": "HD2670A4772D04BAFBA2A957F93416608", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall not apply with respect to any drug or biological product after the\n\t\t\t\tdate on which the drug or biological product is approved or licensed by the\n\t\t\t\t", "@entity-type": "act", "#text": "Subparagraph\n\t\t\t\t(A)", "@value": "Patient Protection and Affordable Care Act/s:90008/ss:e/p:3/sp:A"}, {"#tail": " for marketing for any indication other than the\n\t\t\t\ttreatment of a rare disease or condition.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "\n                "}, "enum": {"#tail": "\n              ", "#text": "(B)"}, "header": {"#tail": "\n              ", "#text": "Limitation"}, "#text": "\n              ", "@id": "HC21879BEC09B4C4DBE91E58F56E00989", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", except that in the case of any drug or\n\t\t\t\tbiological product that has not been designated under ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of the\n\t\t\t\t", "@entity-type": "act", "#text": "section 45C(d)(1)", "@value": "Internal Revenue Code of 1986/s:45C/ss:d/p:1"}, {"#tail": "\n                ", "@entity-type": "act", "#text": "Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986"}], "@entity-type": "act", "#text": "\n                  ", "@value": "Internal Revenue Code of 1986/s:45C/ss:d/p:1"}, {"#tail": " for a particular indication, determinations\n\t\t\t\tunder such ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of the\n\t\t\t\t", "@entity-type": "act", "#text": "section 526", "@value": "Federal Food, Drug, and Cosmetic Act/s:526"}, {"#tail": "\n                ", "@entity-type": "act", "#text": "Federal Food, Drug and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}], "@entity-type": "act", "#text": "\n                  ", "@value": "Federal Food, Drug and Cosmetic Act/s:526"}, {"#tail": " shall be made on the basis of the facts and\n\t\t\t\tcircumstances as of the date such drug or biological product is approved or\n\t\t\t\tlicensed by the ", "@entity-type": "act", "#text": "section 45C(d)(1)", "@value": "Internal Revenue Code of 1986/s:45C/ss:d/p:1"}, {"#tail": " for marketing for the treatment of\n\t\t\t\tsuch disease or\n\t\t\t\tcondition.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "term": {"#tail": " has the meaning given such term under ", "#text": "rare disease or\n\t\t\t\tcondition"}, "#text": "In this paragraph, the term "}, "enum": {"#tail": "\n              ", "#text": "(C)"}, "header": {"#tail": "\n              ", "#text": "Rare disease or\n\t\t\t\tcondition"}, "#text": "\n              ", "@id": "HE2230F38AA6748E3984C9EFCD2E6E70C", "@commented": "no"}], "enum": {"#tail": "\n            ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Exclusion of\n\t\t\t\torphan drug sales"}, "#text": "\n            ", "@id": "H1E5CD89FCF6A4D7FA67EB61CC3A18FB8", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HF27DB0DDD42C4EFB8F39B677E227B40C"}, "#text": "\n        ", "@id": "HC6CAA135FAAF4644886FCF712C033886", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The amendment made by this section shall take effect as if\n\t\t\t included in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ").", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 9008 of the \n            Patient Protection and Affordable Care Act", "@value": "Patient Protection and Affordable Care Act/s:9008"}, {"#tail": ".; ", "@entity-type": "uscode", "#text": "26\n\t\t\t U.S.C. 4001 note prec", "@value": "usc/26/4001/note"}], "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": "\n          \n          ", "@parsable-cite": "pl/111/148", "#text": "Public Law 111\u2013148", "@legal-doc": "public-law"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "H26DA77CC8C8441FBB55E0978A9162317"}], "#text": "\n      ", "@id": "H0919A08248C6450AA5F781AFC9E3A146"}], "#text": "\n\t\t", "@id": "H217770B9975B48CAAAB6B8922A9E76CD"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S1128 IS: Preserving Access to Orphan Drugs Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}